Source: https://litigation.consusgroup.com/2017/02/23/claim-construction-chart-b-braun-melsungen-ag-et-al-v-becton-dickinson-and-company-et-al-bdx/
Timestamp: 2019-04-23 06:46:21+00:00

Document:
02-23-2017 – This patent litigation hasn’t yet received any mainstream news coverage, but if you’re battling insomnia, here’s a surefire cure in a claim construction chart. B. Braun Melsungen AG is alleging infringement of 10 U.S. patents relating to IV catheter safety mechanisms in the plaintiff-friendly District of Delaware.
Company and Becton Dickinson Infusion Therapy Systems, Inc. (collectively, “BD” or “Defendants”), through their attorneys, hereby submit their Joint Claim Construction Chart identifying the term(s)/phrase(s) of the claims in issue, including agreed constructions and each party’s proposed construction of disputed claim language with citation(s) to the intrinsic evidence in support of their respective proposed constructions.
“needle protective device . . .
Defendants have identified the § 112 arguments that they may raise during claim construction briefing in this column. Defendants reserve the right to raise § 112 positions included in their initial invalidity contentions or any amended invalidity contentions not raised during claim construction briefing later in the case, including during expert discovery and summary judgment.
The parties’ citations to the ’735 patent specification are representative for the ’762, ’626, ’728, ’463, and ’735 patents (the “Woehr/Raines” family) which share a specification.
• File History of U.S. Appl. No.
Response to Office Action, p.
’626 patent, claim 11 function term under 35 U.S.C. § 112, ¶ 6.
Given that Plaintiffs received Defendants’ alternative construction at 1:18 p.m. on February 23, 2017, Plaintiffs reserve the right to provide an opposing construction at a later date.
• File History of U.S. Appl. No. 10/520,325; Amendment, pp.
Defendants disagree that Plaintiffs are entitled to any additional time to propose opposing claim constructions.
’249 patent, claim 1 Plaintiffs contend that this is not a means plus function term under 35 U.S.C. § 112, ¶ 6.
9, 12, 15, 20, 23, 30; Abstract; col. 1, ll. 1518; col. 1, ll. 52-56; col. 2, ll. 15-50; col. 3, ll. 3236; col. 4, ll. 45-54; col.
FIG. 1; col. 5, ll. 45-62 (including incorporation by reference of U.S. Pat. No. 6,616, 630); FIG. 3; FIG. 4; col. 6, l. 46 – col.
7, l. 4 (including incorporation by reference of U.S. patent application Ser. No.
• ’247 patent at FIGS.
The parties’ citations to the ’247 patent specification are representative for the ’249, ’641, and ’247 patents (the “Woehr/Zerbes” family) which share a specification.
22 o ’630 patent, Col.
2:47-49 o ’630 patent, Col.
3:19-20 o ’630 patent, Col.
3:46-55 o ’630 patent, Col.
5:54-6:9 o ’630 patent, Col.
6:27-41 o ’630 patent, Col.
7:9-13 o ’630 patent, Col.
8:61-9:3 o ’630 patent, Col.
9:23-35 o ’630 patent, Col.
9:61-10:4 o ’630 patent, Col.
10:17-36 o ’630 patent, Col.
10:58-11:2 o ’630 patent, Col.
6:56-58, Col. 7:5759, incorporating by reference tip protectors disclosed in U.S. Appl. No.
U.S. Appl. No. 11/496,769 issued as U.S. Patent No. 8,382,718, which is cited throughout this document.
reference tip protectors with an opening that cants over to grip the needle disclosed in U.S. Patent No.
FIGS. 1-5 o ’419 patent, Col.
1:19-28 o ’419 patent, Col.
1:43-58 o ’419 patent, Col.
2:41-47 o ’419 patent, Col.
3:12-30 o U.S. Pub. No.
FIGS. 1-8 o U.S. Pub. No.
2005/0075609, • ’247 patent, Col. 6:56-58, Col. 7:57-59, incorporating by reference tip protectors disclosed in U.S.
U.S. Appl. No. 10/677,810published as U.S. Publication No. 2005/0075609, which is cited throughout this document.
U.S. Appl. No. 10/954,041issued as U.S. Patent No. 7,651,476, which is cited throughout this document.
FIGS. 1-10 o ’476 patent, Col.
1:37-62 o ’476 patent, Col.
2:54-65 o ’476 patent, Col.
3:3-11 o ’476 patent, Col.
3:24-46 o ’476 patent, Col.
3:57-63 o ’476 patent, Col.
3:66-4:4 o ’476 patent, Col.
4:63-5:3 o ’476 patent, Col.
5:21-6:38 o ’476 patent, Col.
Notwithstanding Defendants’ offer to jointly stipulate to an extension of time to file the joint claim chart and thereby afford additional time for Plaintiffs to consider the alternative constructions, Plaintiffs declined that offer. No.
FIGS. 1-8 o U.S. Pub.
• File History of U.S. Appl. No. 11/592,595; Amendment, p.
• File History of U.S. Appl. No. 13/407,395; Amendment, p.
• File History of U.S. Appl. No. 14/062,081; Amendment, pp.
’728 patent, claim 9 needle protective device positioned proximal of the valve and at least in part: (i) around the needle, and (ii) distal of the proximal end of the second hub ’735 patent†: Abstract; col. 1, ll. 24-49; col. 2, ll.
’728 patent, claim 24 needle protective device positioned, at least in part: (i) around the needle, (ii) between the valve and the proximal end of the needle hub ’735 patent†: Abstract; col. 1, ll. 24-49; col. 2, ll.
FIG. 4; col. 6, l. 54 – col.
7, l. 12 (including incorporation by reference of U.S. patent application Ser. No.
No. 6,709,419, U.S. patent application Ser. No. 10/677,810; U.S. patent application Ser. No. 10/954,041); FIG. 6; col. 7, l. 61 – col. 8, l. 20 (including incorporation by reference of U.S. patent application Ser. No. 11/496,769); FIG. 7; FIG. 9D; col. 9, ll. 50-56; col. 10, ll. 1-15; FIG. 13; col. 11, l. 13 – col. 12, l.
• ’641 patent at FIGS.
application Ser. No. 10/468,923, U.S. Pat.
No. 7,125,397); FIG. 14 disclosed in U.S.
7:16-56 o ’630 patent, Col.
8:23-36 o ’630 patent, Col.
• ’641 patent, FIGS. 67, col. 6:64-7:3, col.
7:65-67, incorporating by reference tip protectors disclosed in U.S. Appl. No.
• ’641 patent at col. 7:6-12, incorporating by reference tip protectors with an opening that cants over to grip the needle disclosed in U.S. Patent No.
6:64-7:3, col. 7:65-67, incorporating by reference tip protectors disclosed in U.S.
• ’641 patent at col. 7:6-12, incorporating by reference tip protectors with an opening that cants over to grip the needle disclosed in U.S.
structure that transfers an external force 11; col. 2, ll. 43-50; col. 3, ll. 27-31; col. 6, ll. 1415; col. 6, ll. 23-34; col. 6, ll. 40-43; col. 7, ll. 2026; col. 8, ll. 36-40; col. 8, ll. 45-49; col. 8, ll. 5254; col. 10, ll. 7-9; col.
10, ll. 14-16; col. 10, ll. 33-37; col. 10, ll. 54-56; col. 11, ll. 7-19; col. 12, ll. 4-12; FIG. 2; FIG. 4; FIG. 8B; FIG. 10A; FIG.
• File History of U.S. Appl. No. 11/592,595; Amendment; p.
15, 17 Plaintiffs contend that this is not a means plus function term under 35 U.S.C. § 112, ¶ 6.
Not indefinite under § 112.
Given that Plaintiffs received Defendants’ alternative construction at 1:18 p.m. on February 23, 2017, Plaintiffs reserve the right to provide an opposing ’605 patent†††: claims 1, 18, 25; Abstract; col. 3, l.
3 – col. 5, l. 20; FIGS.
43B; col. 15, l. 64 – col.
118, 123, 124, ’605 patent, cols.
The parties’ citations to the ’605 patent specification are representative for the ’454, ’530, and ’605 patents (the “Kuracina” family) which share a specification.
construction at a later date. FIGS. 61-63; col. 20, l.
64 – col 22, l. 11; FIGS. 65-69; col. 22, l. 66 – col. 21, l. 58; FIGS. 7178; col 24, l. 62 – col. 27, l. 52; FIGS. 84-85; col.
28, l. 65 – col. 30, l. 3; FIGS. 88-90; col. 30, l.
col. 43, l. 54 – col. 44, l.
• U.S. Patent No. 7,927,314 (“’314 patent”) FH Aug.
Attorneys for B. Braun Melsungen AG, B.
Braun Medical Industries Sdn. Bhd., and B.
Next New Patent Litigation: Cardshark, LLC v. Five Below, Inc.

References: § 112
 § 112
 § 112
 § 112
 § 112
 § 112
 v.